J9277 — Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
J9277 is a HCPCS Level II code for injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J9277
- Long descriptor
- Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
- Short descriptor
- Pembrolizumab 1mg berahyalur
- Added
- April 1, 2026
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9277
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9277 is not quite right, the correct code is very often within a few positions of it.
- J9269Injection, tagraxofusp-erzs, 10 micrograms
- J9270Injection, plicamycin, 2.5 mgterminated
- J9271Injection, pembrolizumab, 1 mg
- J9272Injection, dostarlimab-gxly, 10 mg
- J9273Injection, tisotumab vedotin-tftv, 1 mg
- J9274Injection, tebentafusp-tebn, 1 microgram
- J9275Injection, cosibelimab-ipdl, 2 mg
- J9276Injection, zanidatamab-hrii, 2 mg
- J9278Injection, carboplatin (avyxa), 1 mg
- J9280Injection, mitomycin, 5 mg
- J9281Mitomycin pyelocalyceal instillation, 1 mg
- J9282Mitomycin, intravesical instillation, 1 mg
- J9285Injection, olaratumab, 10 mg
- J9286Injection, glofitamab-gxbm, 2.5 mg
- J9289Injection, nivolumab, 2 mg and hyaluronidase-nvhy
- J9292Injection, pemetrexed dipotassium, 10 mg
Questions about J9277
What is HCPCS code J9277?
J9277 is a HCPCS Level II code for injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9277?
The CMS HCPCS file marks J9277 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J9277 paid under the physician fee schedule?
J9277 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).